Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBurke, Joseph Patricken_US
dc.contributor.authorAljishi, Manafen_US
dc.contributor.authorFrancis, Leoen_US
dc.contributor.authorHoy, Wendyen_US
dc.contributor.authorDivi, Dakshinamurthyen_US
dc.contributor.authorCherian, Royen_US
dc.contributor.authorFrazier, Jeremyen_US
dc.contributor.authorGobe, Glendaen_US
dc.contributor.authorGois, Pedroen_US
dc.contributor.authorGovindarajulu, Sridevien_US
dc.contributor.authorHuynh, Sonnyen_US
dc.contributor.authorJesudason, Shilpanjalien_US
dc.contributor.authorJohn, Georgeen_US
dc.contributor.authorMadhan, Krishanen_US
dc.contributor.authorMallett, Andrewen_US
dc.contributor.authorManickam, Vallien_US
dc.contributor.authorMutatiri, Clysonen_US
dc.contributor.authorNg, Shu-Kayen_US
dc.contributor.authorThet, Zawen_US
dc.contributor.authorTrnka, Peteren_US
dc.contributor.authorVenuthurupalli, Sree Krishnaen_US
dc.contributor.authorRanganathan, Dwarakanathanen_US
dc.identifier.citationBurke JP, Aljishi M, Francis L, Hoy W, Divi D, Cherian R, Frazier J, Gobe G, Gois P, Govindarajulu S, Huynh S, Jesudason S, John G, Madhan K, Mallett A, Manickam V, Mutatiri C, Ng SK, Thet Z, Trnka P, Venuthurupalli SK, Ranganathan D. Protocol and establishment of a Queensland renal biopsy registry in Australia. BMC Nephrol. 2020 Aug 1;21(1):320. doi: 10.1186/s12882-020-01983-7en_US
dc.description.abstractRenal biopsy is often required to obtain information for diagnosis, management and prognosis of kidney disease that can be broadly classified into acute kidney injury (AKI) and chronic kidney disease (CKD). The most common conditions identified on renal biopsy are glomerulonephritis and tubulo-interstitial disorders. There is a paucity of information on management strategies and therapeutic outcomes in AKI and CKD patients. A renal biopsy registry will provide information on biopsy-proven kidney disorders to improve disease understanding and tracking, healthcare planning, patient care and outcomes. A registry of patients, that includes biopsy-proven kidney disease, was established through the collaboration of nephrologists from Queensland Hospital and Health Services and pathologists from Pathology Queensland services. The registry is in keeping with directions of the Advancing Kidney Care 2026 Collaborative, established in September 2018 as a Queensland Health initiative. Phase 1 of the registry entailed retrospective acquisition of data from all adult native kidney biopsies performed in Queensland, Australia, from 2002 to 2018. Data were also linked with the existing CKD.QLD patient registry. From 2019 onwards, phase 2 of the registry involves prospective collection of all incident consenting patients referred to Queensland public hospitals and having a renal biopsy. Annual reports on patient outcomes will be generated and disseminated. Establishment of the Queensland Renal Biopsy Registry (QRBR) aims to provide a profile of patients with biopsy-proven kidney disease that will lead to better understanding of clinico-pathological association and facilitate future research. It is expected to improve patient care and outcomes.en_US
dc.publisherBiomed Centralen_US
dc.relation.ispartofBMC nephrologyen_US
dc.subjectKidney diseasesen_US
dc.subjectRenal biopsyen_US
dc.titleProtocol and establishment of a Queensland renal biopsy registry in Australiaen_US
item.fulltextNo Fulltext-
Appears in Sites:Gold Coast Health Publications
Show simple item record

Page view(s)

checked on Jan 28, 2023

Google ScholarTM



Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.